… In the current study, the median time from biochemical recurrence to prostate cancer–specific
mortality was not reached after 16 years of follow-up. However, using the clinical variables …

… Biochemical recurrence develops in almost one-third of men with prostate cancer after …
molecular imaging in men with biochemically recurrent prostate cancer. First, radiation therapy, …

… with prostate cancer (PCa) with biochemical recurrence (BCR… , this prostate-specific antigen
(PSA)-only recurrence is a … progress beyond PSA-only recurrence. Adjuvant therapy for radi…

… The assessment of the risk of biochemical recurrence (BCR) is critical in the management
of males with prostate cancer (PC). Over the past decades, a comprehensive effort has been …

… as prostate cancer mortality and biochemical recurrence among healthy population and
among the diagnosed patients to specifically evaluate the role of adiposity on prostate cancer …

… to management after recurrent PCa. Search terms included prostate cancer recurrence, salvage
… This review discusses the contemporary management of biochemical recurrence (BCR) …

… term biochemical recurrence following radical retropubic prostatectomy with adjusted risk
factors because of a downward stage migration of prostate cancer … of biochemical recurrence of …

… treatment of localized prostate cancer does not … prostate cancer, some patients can develop
recurrence of disease identified via a prostate-specific antigen blood test (ie, biochemical …

… newly diagnosed prostate cancer (PCA). Prior series have characterized a biochemical failure
(BF… It is now apparent that the risk for reemergence of a detectable serum prostate specific …

… in men who shows rising prostate-specific antigen (PSA) in … at a high risk of death from
prostate cancer in the longer term. … Association of Urology biochemical recurrence Risk Groups), …